KYLE FAYE: Open Payments
NPI 1629447065 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 29 payments from 8 companies in 2025. Trend: 2023 $47 · 2024 $161 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 10 | $205 |
| Gilead Sciences, Inc. | 8 | $173 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Verona Pharma, Inc. | 2 | $61 |
| Novo Nordisk Inc | 2 | $52 |
| Amgen Inc. | 2 | $46 |
| Exact Sciences Corporation | 1 | $31 |
| ABBVIE INC. | 1 | $28 |
Products named: DOVATO, PIFELTRO, Ohtuvayre, REPATHA, Cologuard Collection Kit, Rybelsus, MAVYRET, Wegovy.
Industry payments across PA — which companies pay providers there.
